Abstract
Current chemical treatments for cerebrovascular disease and neurological disorders have limited efficacy in tissue repair and functional restoration. Induced pluripotent stem cells (iPSCs) present a promising avenue in regenerative medicine for addressing neurological conditions. iPSCs, which are capable of reprogramming adult cells to regain pluripotency, offer the potential for patient-specific, personalized therapies. The modulation of molecular mechanisms through specific growth factor inhibition and signaling pathways can direct iPSCs’ differentiation into neural stem cells (NSCs). These include employing bone morphogenetic protein-4 (BMP-4), transforming growth factor-beta (TGFβ), and Sma-and Mad-related protein (SMAD) signaling. iPSC-derived NSCs can subsequently differentiate into various neuron types, each performing distinct functions. Cell transplantation underscores the potential of iPSC-derived NSCs to treat neurodegenerative diseases such as Parkinson’s disease and points to future research directions for optimizing differentiation protocols and enhancing clinical applications.
| Original language | English |
|---|---|
| Article number | 1350 |
| Journal | Biomedicines |
| Volume | 12 |
| Issue number | 6 |
| DOIs | |
| State | Published - Jun 2024 |
Bibliographical note
Publisher Copyright:© 2024 by the authors.
Keywords
- BMP-4 protein
- SMAD proteins
- induced pluripotent stem cells
- neural stem cells
- transforming growth factor beta
- transplantation
Fingerprint
Dive into the research topics of 'Neuronal Cell Differentiation of iPSCs for the Clinical Treatment of Neurological Diseases'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver